Mindfulness and dual-task training for mild cognitive impairment after stroke
Tests mindfulness with dual-task training in people with mild cognitive impairment after stroke.
Plain-language title generated from the registry record
Registry title: Mindfulness With Dual-Task Training in Post-Stroke Mild Cognitive Impairment
Key facts
- Where
- Nanjing, ChinaSee the site
Where in China
- Nanjing Mingzhou Rehabilitation HospitalNanjing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Nanjing Mingzhou Rehabilitation Hospital
- Trial code
- NCT07603102
- Record updated
- 22 May 2026
- Original description
This study aims to investigate whether a combined intervention of mindfulness and dual-task training can improve cognitive function and physical performance in individuals with mild cognitive impairment after stroke.Read full original descriptionShow less
Mindfulness Combined With Dual-Task Training for Post-Stroke Mild Cognitive Impairment: A Randomized Controlled Trial
This study aims to investigate whether a combined intervention of mindfulness and dual-task training can improve cognitive function and physical performance in individuals with mild cognitive impairment after stroke.
Inclusion: Diagnosis of stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI); Time since stroke onset ≥3 months and medically stable; Presence of mild cognitive impairment after stroke, defined by a Montreal - - Montreal Cognitive Assessment (MoCA) score < 26; Mini-Mental State Examination (MMSE) score ≥ 24; Ability to walk independently with or without an assistive device for at least 10 meters; Stable medication regimen for at least 4 weeks prior to enrollment; Ability to understand study instructions and provide written informed consent.
Exclusion: Severe aphasia, visual impairment, hearing impairment, or communication disorders that interfere with assessment or training participation; Severe depression or other major psychiatric disorders; Other neurological diseases affecting cognition or movement (e.g., Parkinson's disease, multiple sclerosis, traumatic brain injury); Severe musculoskeletal, cardiovascular, or systemic diseases that contraindicate exercise participation; Unstable medical condition or recurrent stroke during the study period; Participation in other structured cognitive or rehabilitation intervention programs within the past 3 months; Inability to safely complete the training protocol as determined by the study investigators.